Maricann Group Announces Proposed Acquisition

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI) (“Maricann” or “the Company”), is pleased to announce a non-binding term sheet for the proposed acquisition of all outstanding shares of Haxxon AG (“Haxxon”) for an aggregate purchase price of CHF 8,000,000, of which CHF 2,000,000 will be payable in cash and the remainder in common stock of the Company at the 20-day vwap prior to closing. The arrangement provides Maricann a period of exclusivity to allow the Company to complete the necessary due diligence and enter into a binding definitive agreement.
Haxxon is based in Regensdorf, Switzerland; an industrial suburb of Zurich located less than 5 minutes from the airport. Haxxon operates in a 60,000 sq. ft. facility where it cultivates female hemp cannabis flowers, with less than 1% THC to the European market. Current production is 2,210 kg of dried cannabis flower with costs of CHF 650/kg and realized selling prices of CHF 2,600 to CHF 3,500, with higher prices paid for less THC.
The acquisition of Haxxon, if completed, will allow Maricann to produce cannabis flowers in Switzerland which would then be manufactured into finished products. These products would include cannabis vape cartridges, cannabis pre-roll cigarettes with no tobacco, unlike other current offerings, and CBD isolates in the form of finished dose pharmaceuticals, including VesiSorb capsules.
The transaction is subject to completion of due diligence, the entering into definitive binding documentation and receipt of all necessary approvals. The transaction is targeted to close by March 30, 2018.
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario, Canada where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, capable of producing 95,000 kg of dry cannabis flower per year to support existing and future patient growth.
For more information about Maricann, please visit our website at www.maricann.com.
Forward Looking Information
Certain statements in this document, including statements with respect to the transaction, contain forward-looking statements which can be identified by the use of forward-looking terminology such as “believes”, “expects”, “may”, “desires”, “will”, “should”, “projects”, “estimates”, “contemplates”, “anticipates”, “intends”, or any negative such as “does not believe” or other variations thereof or comparable terminology. No assurance can be given that potential future results or circumstances described in the forward-looking statements will be achieved or will occur. By their nature, these forward-looking statements, necessarily involve risks and uncertainties, including those discussed herein, that could cause actual results to significantly differ from those contemplated by these forward-looking statements. Such statements reflect the view of the Company with respect to the transaction and future events, and are based on information currently available to the Company and on assumptions, which it considers reasonable. Management cautions readers that the assumptions relative to the future events, several of which are beyond Management’s control, could prove to be incorrect, given that they are subject to certain risk and uncertainties, and that actual results may differ materially from those projected. Factors which could cause results or events to differ from current expectations include, among other things: the parties not arriving to a definitive agreement, uncertainties with respect to obtaining all required approvals, inability for Maricann to integrate Hexxon and realize the benefits of the acquisition of Hexxon, fluctuations in operating results; the impact of general economic, industry and market conditions; the ability to recruit and retain qualified employees; fluctuations in cash flow; increased levels of outstanding debt and obligations under a capital lease; expectations regarding market demand for particular products and the dependence on new product development; the impact of market change; and the impact of price and product competition. Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking information.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.